CN112813134A - Chromogenic medium, preparation method and strain detection method - Google Patents

Chromogenic medium, preparation method and strain detection method Download PDF

Info

Publication number
CN112813134A
CN112813134A CN202110372160.9A CN202110372160A CN112813134A CN 112813134 A CN112813134 A CN 112813134A CN 202110372160 A CN202110372160 A CN 202110372160A CN 112813134 A CN112813134 A CN 112813134A
Authority
CN
China
Prior art keywords
parts
lactobacillus
microorganism belonging
culture medium
chromogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110372160.9A
Other languages
Chinese (zh)
Other versions
CN112813134B (en
Inventor
贾洪利
杨玲
仵红岩
赵林森
齐世华
郭红敏
任磊
霍世和
申朋
路江浩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hebei Inatural Biotechnology Co ltd
Original Assignee
Hebei Inatural Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebei Inatural Biotechnology Co ltd filed Critical Hebei Inatural Biotechnology Co ltd
Priority to CN202110372160.9A priority Critical patent/CN112813134B/en
Publication of CN112813134A publication Critical patent/CN112813134A/en
Application granted granted Critical
Publication of CN112813134B publication Critical patent/CN112813134B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045Culture media therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to the technical field of microorganisms, and provides a chromogenic culture medium which comprises the following components: 8-12 parts of maltose, 4-6 parts of yeast powder, 6-14 parts of peptone, 0.4-0.8 part of L-cysteine hydrochloride, 4-6 parts of sodium acetate, 2-4 parts of dipotassium hydrogen phosphate, 2-4 parts of triammonium citrate, 0.2-0.5 part of magnesium sulfate, 0.02-0.06 part of manganese sulfate, 13-17 parts of agar, 1-2 parts of tween and 900-1000 parts of distilled water. Through the technical scheme, the problem that other small amounts of unidentified strains cannot be mixed in the leavening agent consisting of the lactobacillus bulgaricus and the streptococcus thermophilus for detection in the prior art is solved.

Description

Chromogenic medium, preparation method and strain detection method
Technical Field
The invention relates to the technical field of microorganisms, in particular to a chromogenic medium, a preparation method and a strain detection method.
Background
The common yoghurt in the market is a milk product which is prepared by taking fresh milk as a raw material, sterilizing the fresh milk by a bus, adding a starter (a starter) into the milk, fermenting the milk, and cooling and filling the fermented milk.
The selection of the strains plays an important role in the quality of the leavening agent, proper strains can be selected according to the variety of the produced fermented dairy products, comprehensive selection is carried out on the characteristics of the optimal temperature, the acid production capacity, whether viscous substances are produced or not of the strains, and the symbiosis among the strains is also considered so as to enable the strains to be beneficial to each other in production and propagation. The yogurt is produced by adopting freeze-dried strains which are mainly a mixed starter of lactobacillus bulgaricus and streptococcus thermophilus, wherein the streptococcus thermophilus produces acid, and the lactobacillus bulgaricus produces acid and flavor.
The quality of the leavening agent is strictly controlled, and the requirements on the microorganism of the leavening agent are as follows: detecting the viable count of the lactobacillus according to GB 4789.35; mould and yeast testing, following GB 4789.15; enterobacteriaceae assays, following SN/T0738; staphylococcus aureus detection, following GB 4789.10; listeria monocytogenes, following GB 4789.30;
the method prevents a small amount of unidentified strains from being mixed into a leavening agent only comprising lactobacillus bulgaricus and streptococcus thermophilus, but in the conventional detection process, non-lactic acid bacteria and mildew fermentation detection is carried out on the product, so that a detection method for pollution of other non-local lactic acid bacteria is lacked, and a standard detection method is not available at present. For example, if a starter composed of only lactobacillus bulgaricus and streptococcus thermophilus is mixed with one or more of lactobacillus plantarum, lactobacillus casei, lactobacillus paracasei, lactobacillus rhamnosus, lactobacillus acidophilus buchneri and the like which should not be present, the detection cannot be performed by the detection method, which is a technical problem which has been difficult to solve for a long time.
There are many media for culturing lactic acid bacteria, but in the case of both Lactobacillus bulgaricus and Streptococcus thermophilus, there are cases where difficulty in growth is encountered, and therefore a suitable medium should be selected. In general, lactic acid bacteria are tolerant to low pH values but are very sensitive to other adverse conditions, e.g. some samples cannot be frozen before inoculation and the selection of a suitable medium is also a difficult problem to solve.
The chromogenic culture medium utilizes the specificity of bacteria, combines a specific enzyme substrate by a selective culture method, allows the target bacteria to grow and present a color or other colony characteristics which are obviously different from the colonies of other growing bacteria, and thereby identifies the target bacteria. The most important advantage of the chromogenic culture is that the specimen is directly used, and the separation culture and the identification of bacteria are combined together, so that the effect of direct identification while separation is achieved. To date, there have been many chromogenic cultures such as Candida chromogenic medium, group B Streptococcus chromogenic medium, Staphylococcus aureus chromogenic medium, etc., but Lactobacillus bulgaricus and Streptococcus thermophilus chromogenic medium have not been found.
Disclosure of Invention
The invention provides a chromogenic medium, a preparation method and a strain detection method, and solves the problem that in the prior art, a small amount of unidentified strains cannot be mixed in a leavening agent consisting of lactobacillus bulgaricus and streptococcus thermophilus for detection.
The technical scheme of the invention is as follows:
a chromogenic culture medium comprises the following components in parts by weight: 8-12 parts of maltose, 4-6 parts of yeast powder, 6-14 parts of peptone, 0.4-0.8 part of L-cysteine hydrochloride, 4-6 parts of sodium acetate, 2-4 parts of dipotassium hydrogen phosphate, 2-4 parts of triammonium citrate, 0.2-0.5 part of magnesium sulfate, 0.02-0.06 part of manganese sulfate, 13-17 parts of agar, 1-2 parts of tween and 900-1000 parts of distilled water.
As a further technical scheme, the chromogenic medium further comprises 0.01-0.015 part of vancomycin.
As a further technical scheme, the chromogenic medium further comprises 0.003-0.004 part of bromocresol purple ethanol solution.
A preparation method of a chromogenic medium comprises the following steps:
s1, weighing the raw materials according to the formula for later use;
s2, dissolving maltose, yeast powder, peptone, L-cysteine hydrochloride, sodium acetate, dipotassium hydrogen phosphate, triammonium citrate, magnesium sulfate, manganese sulfate, agar and tween in distilled water, heating and boiling until completely dissolving, sterilizing under high pressure, and cooling to 50 ℃ to obtain an S2 culture medium;
s3, adding vancomycin into the S2 culture medium to obtain an S3 culture medium for later use;
and S4, adding the bromocresol purple ethanol solution into the S3 culture medium, uniformly mixing, and pouring a flat plate to obtain a chromogenic culture medium for later use.
As a further technical scheme, in the step S2, the autoclaving temperature is 120-125 ℃, the time is 15-20 min, and the temperature is cooled to 50 ℃ for standby.
A detection method using a chromogenic medium comprises the following steps:
a1, adding the bacterial powder to be detected into sterile normal saline to prepare bacterial powder diluent;
a2, adding the bacterial powder diluent in the step A1 to the surface of the chromogenic medium for coating;
a3, observing the formation of sterile colonies in anaerobic culture.
As a further technical scheme, the bacterial powder to be detected comprises at least 1 microorganism of microorganisms belonging to streptococcus thermophilus, microorganisms belonging to lactobacillus bulgaricus, microorganisms belonging to lactobacillus plantarum, microorganisms belonging to lactobacillus casei, microorganisms belonging to lactobacillus paracasei, microorganisms belonging to lactobacillus rhamnosus, microorganisms belonging to lactobacillus acidophilus, microorganisms belonging to lactobacillus buchneri and microorganisms belonging to alkaline environment or ammonia gas produced by metabolism.
As a further technical scheme, the bacterial powder to be detected is one of the following:
a test bacterium containing a microorganism belonging to Streptococcus thermophilus and a microorganism belonging to Lactobacillus bulgaricus;
a test bacterium containing a microorganism belonging to Streptococcus thermophilus and a microorganism belonging to Lactobacillus bulgaricus and also a microorganism which is metabolized to produce ammonia gas or an alkaline environment.
The invention has the beneficial effects that:
1. the invention provides a chromogenic medium which can inhibit the growth of lactobacillus bulgaricus and streptococcus thermophilus on the medium, and the discoloration of other types of lactic acid bacteria or ammonia bacteria generated by metabolism after the growth of the lactic acid bacteria or the ammonia bacteria on the medium, thereby enhancing the maintenance of the product quality.
2. In the preparation process of the culture medium, vancomycin and bromocresol purple dissolving liquid are added, so that growth of lactobacillus bulgaricus and streptococcus thermophilus on the culture medium can be inhibited only in bacteria to be detected containing microorganisms of streptococcus thermophilus and lactobacillus bulgaricus; other lactic acid producing bacteria used in a composition containing Streptococcus thermophilus and microorganisms other than Lactobacillus bulgaricus, or strains which metabolically produce ammonia gas, develop discoloration upon growth on this medium, and a medium useful as a selective medium for the aforementioned assay.
3. The components of the culture medium are mutually cooperated, and the growth of lactobacillus bulgaricus and streptococcus thermophilus can be inhibited by adding vancomycin, while the growth of lactobacillus plantarum, lactobacillus casei, lactobacillus paracasei, lactobacillus rhamnosus, lactobacillus acidophilus and lactobacillus buchneri is inconsistent.
4. When the morphology of colonies and the shape of bacteria are similar, the identification of the species requires professional knowledge. Therefore, a culture method is required to be used for mixing trace lactobacillus casei and the like into a fermenting agent mainly comprising streptococcus thermophilus and lactobacillus bulgaricus, carrying out metabolic analysis and optimizing a culture medium; the optimal addition amount of vancomycin is selected according to the resistance of the lactobacillus to antibiotics, and the vancomycin is added into the optimized culture for culture, so that streptococcus thermophilus and lactobacillus bulgaricus are just inhibited, and the mixed lactobacillus plantarum, lactobacillus casei, lactobacillus paracasei, lactobacillus rhamnosus, lactobacillus acidophilus and lactobacillus buchneri can grow. And then through the color development principle of bromocresol purple, the culture medium and the bacterial colony display different colors for judgment through acid or alkaline color taking generated after metabolism of different microorganisms.
Drawings
The present invention will be described in further detail with reference to the accompanying drawings and specific embodiments.
FIG. 1 is a photograph of a culture medium test of a first bacterial powder to be tested;
FIG. 2 is a photo of the detection of the culture medium of the second bacterial powder to be detected;
FIG. 3 is a photograph of the medium detection of the third bacterial powder to be tested.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any inventive step, are intended to be within the scope of the present invention.
Example 1
S1, medium material composition: 10g/L of maltose, 5g/L of yeast powder, 10g/L, L g/L of peptone-cysteine hydrochloride 0.6g/L, 5g/L of sodium acetate, 3g/L of dipotassium phosphate, 3g/L of ammonium citrate tribasic, 0.3g/L of magnesium sulfate, 0.04g/L of manganese sulfate, 15g/L of agar, 801 g/L of tween and the balance of distilled water;
s2, dissolving maltose, yeast powder, peptone, L-cysteine hydrochloride, sodium acetate, dipotassium hydrogen phosphate, triammonium citrate, magnesium sulfate, manganese sulfate, agar and Tween 80 in distilled water, heating and boiling until the components are completely dissolved, sterilizing at 121 ℃ under high pressure for 10min, and cooling to 50 ℃ to obtain an S2 culture medium;
s3, adding vancomycin into the S2 culture medium, wherein the addition amount of the vancomycin is 1 vancomycin added into each 100ml of sterile culture medium, and the content of each vancomycin is 1mg to obtain an S3 culture medium for later use;
s4, adding the bromocresol purple ethanol solution into the S3 culture medium, wherein a color-changing component, namely bromocresol purple enables the culture medium to change color in environments with different acid and alkali, adding 300uL of 1.5% bromocresol purple (w/v, ethanol is dissolved) into each 100ml of the culture medium, uniformly mixing, and pouring a flat plate to obtain a color development culture medium for later use;
s5, weighing 1g of first bacterial powder to be tested in a sterile weighing vessel, adding 9g of sterile normal saline, and oscillating to prepare 1:10 bacterial powder diluent; and (3) sucking 1ml of sample diluent, adding the sample diluent into a culture medium agar plate respectively in the inoculation amount of 0.3ml, 0.3ml and 0.4ml, performing surface coating by using a coating rod, and observing the formation of sterile colonies after anaerobic culture at 36 +/-1 ℃ for 48 +/-2 hours.
FIG. 1 is a photograph of a medium test of the first test powder, the color of the plate is light green, only the microbial composition of Streptococcus thermophilus and Lactobacillus bulgaricus is contained, and no colony of any other bacterial species is grown.
Example 2
S1, medium material composition: 8g/L of maltose, 4g/L of yeast powder, 6g/L, L g of peptone-cysteine hydrochloride 0.4g/L, 4g/L of sodium acetate, 2g/L of dipotassium phosphate, 2g/L of ammonium citrate tribasic, 0.2g/L of magnesium sulfate, 0.02g/L of manganese sulfate, 13g/L of agar, 802 g/L of tween and the balance of distilled water;
s2, dissolving maltose, yeast powder, peptone, L-cysteine hydrochloride, sodium acetate, dipotassium hydrogen phosphate, triammonium citrate, magnesium sulfate, manganese sulfate, agar and Tween 80 in distilled water, heating and boiling until the components are completely dissolved, sterilizing at 120 ℃ under high pressure for 10min, and cooling to 50 ℃ to obtain an S2 culture medium;
s3, adding vancomycin into the S2 culture medium, wherein the addition amount of the vancomycin is 1 vancomycin added into each 100ml of sterile culture medium, and the content of each vancomycin is 1mg to obtain an S3 culture medium for later use;
s4, adding the bromocresol purple ethanol solution into the S3 culture medium, wherein a color-changing component, namely bromocresol purple enables the culture medium to change color in environments with different acid and alkali, adding 300uL of 1.4% bromocresol purple (w/v, ethanol is dissolved) into each 100ml of the culture medium, uniformly mixing, and pouring a flat plate to obtain a color development culture medium for later use;
s5, weighing 1g of second to-be-tested bacterium powder in a sterile weighing vessel, adding 9g of sterile normal saline, and oscillating to prepare 1:10 bacterium powder diluent; and (3) sucking 1ml of sample diluent, adding the sample diluent into a culture medium agar plate respectively in the inoculation amount of 0.3ml, 0.3ml and 0.4ml, performing surface coating by using a coating rod, and observing the formation of sterile colonies after anaerobic culture at 36 +/-1 ℃ for 48 +/-2 hours.
FIG. 2 is a photograph showing the detection of the medium of the second test powder, in which the surrounding medium is changed from light green to light yellow, and which shows that the powder contains one or more of microorganisms belonging to Lactobacillus plantarum, microorganisms belonging to Lactobacillus casei, microorganisms belonging to Lactobacillus paracasei, microorganisms belonging to Lactobacillus rhamnosus, microorganisms belonging to Lactobacillus acidophilus, and microorganisms belonging to Lactobacillus buchneri, in addition to the microorganisms belonging to the Streptococcus thermophilus and microorganisms belonging to Lactobacillus bulgaricus.
Example 3
S1, medium material composition: 12g/L of maltose, 6g/L of yeast powder, 14g/L, L g of peptone-cysteine hydrochloride 0.8g/L, 6g/L of sodium acetate, 4g/L of dipotassium phosphate, 4g/L of ammonium citrate tribasic, 0.5g/L of magnesium sulfate, 0.06g/L of manganese sulfate, 17g/L of agar, 801 g/L of tween and the balance of distilled water;
s2, dissolving maltose, yeast powder, peptone, L-cysteine hydrochloride, sodium acetate, dipotassium hydrogen phosphate, triammonium citrate, magnesium sulfate, manganese sulfate, agar and Tween 80 in distilled water, heating and boiling until the components are completely dissolved, sterilizing at 121 ℃ under high pressure for 12min, and cooling to 50 ℃ to obtain an S2 culture medium;
s3, adding vancomycin into the S2 culture medium, wherein the addition amount of the vancomycin is 1 vancomycin added into each 100ml of sterile culture medium, and the content of each vancomycin is 1mg to obtain an S3 culture medium for later use;
s4, adding the bromocresol purple ethanol solution into the S3 culture medium, wherein a color-changing component, namely bromocresol purple enables the culture medium to change color in environments with different acid and alkali, adding 300uL of 1.4% bromocresol purple (w/v, ethanol is dissolved) into each 100ml of the culture medium, uniformly mixing, and pouring a flat plate to obtain a color development culture medium for later use;
s5, weighing 1g of second to-be-tested bacterium powder in a sterile weighing vessel, adding 9g of sterile normal saline, and oscillating to prepare 1:10 bacterium powder diluent; and (3) sucking 1ml of sample diluent, adding the sample diluent into a culture medium agar plate respectively in the inoculation amount of 0.3ml, 0.3ml and 0.4ml, performing surface coating by using a coating rod, and observing the formation of sterile colonies after anaerobic culture at 36 +/-1 ℃ for 48 +/-2 hours.
FIG. 3 is a photograph showing the detection of the medium of the third test powder containing, in addition to microorganisms belonging to Streptococcus thermophilus and Lactobacillus bulgaricus, one or more of microorganisms capable of metabolizing and decomposing proteins to produce ammonia, such as Bacillus subtilis, etc., which form colonies that change the surrounding medium from light green to deep blue purple.
The present invention is not limited to the above preferred embodiments, and any modifications, equivalent substitutions, improvements, etc. within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims (8)

1. The chromogenic culture medium is characterized by comprising the following components in parts by weight: 8-12 parts of maltose, 4-6 parts of yeast powder, 6-14 parts of peptone, 0.4-0.8 part of L-cysteine hydrochloride, 4-6 parts of sodium acetate, 2-4 parts of dipotassium hydrogen phosphate, 2-4 parts of triammonium citrate, 0.2-0.5 part of magnesium sulfate, 0.02-0.06 part of manganese sulfate, 13-17 parts of agar, 1-2 parts of tween and 900-1000 parts of distilled water.
2. The chromogenic medium according to claim 1, further comprising 0.01 to 0.015 parts of vancomycin.
3. The chromogenic medium according to claim 2, further comprising 0.003 to 0.004 part of bromocresol purple ethanol solution.
4. A preparation method of a chromogenic medium is characterized by comprising the following steps:
s1, weighing the raw materials according to the formula of claim 3 for later use;
s2, dissolving maltose, yeast powder, peptone, L-cysteine hydrochloride, sodium acetate, dipotassium hydrogen phosphate, triammonium citrate, magnesium sulfate, manganese sulfate, agar and tween in distilled water, heating and boiling until the components are completely dissolved, sterilizing at high pressure, and cooling to obtain an S2 culture medium;
s3, adding vancomycin into the S2 culture medium to obtain an S3 culture medium for later use;
and S4, adding the bromocresol purple ethanol solution into the S3 culture medium, uniformly mixing, and pouring a flat plate to obtain a chromogenic culture medium for later use.
5. The method for preparing a chromogenic medium according to claim 4, wherein in step S2, the autoclaving temperature is 120-125 ℃ for 15-20 min, and the temperature is cooled to 50 ℃ for further use.
6. A detection method using a chromogenic medium, comprising the steps of:
a1, adding the bacterial powder to be detected into sterile normal saline to prepare bacterial powder diluent;
a2, adding the bacterial powder diluent in the step A1 to the surface of the chromogenic medium for coating;
a3, observing the formation of sterile colonies in anaerobic culture.
7. The detection method according to claim 6, wherein the bacterial powder to be detected comprises at least 1 microorganism selected from the group consisting of a microorganism belonging to Streptococcus thermophilus, a microorganism belonging to Lactobacillus bulgaricus, a microorganism belonging to Lactobacillus plantarum, a microorganism belonging to Lactobacillus casei, a microorganism belonging to Lactobacillus paracasei, a microorganism belonging to Lactobacillus rhamnosus, a microorganism belonging to Lactobacillus acidophilus, a microorganism belonging to Lactobacillus buchneri, and a microorganism belonging to the metabolic generation of ammonia gas or an alkaline environment.
8. The detection method according to claim 6, wherein the bacterial powder to be detected is one of the following:
a test bacterium containing a microorganism belonging to Streptococcus thermophilus and a microorganism belonging to Lactobacillus bulgaricus;
a test bacterium containing a microorganism belonging to Streptococcus thermophilus and a microorganism belonging to Lactobacillus bulgaricus and also a microorganism which is metabolized to produce ammonia gas or an alkaline environment.
CN202110372160.9A 2021-04-07 2021-04-07 Chromogenic medium, preparation method and strain detection method Active CN112813134B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110372160.9A CN112813134B (en) 2021-04-07 2021-04-07 Chromogenic medium, preparation method and strain detection method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110372160.9A CN112813134B (en) 2021-04-07 2021-04-07 Chromogenic medium, preparation method and strain detection method

Publications (2)

Publication Number Publication Date
CN112813134A true CN112813134A (en) 2021-05-18
CN112813134B CN112813134B (en) 2022-04-26

Family

ID=75862400

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110372160.9A Active CN112813134B (en) 2021-04-07 2021-04-07 Chromogenic medium, preparation method and strain detection method

Country Status (1)

Country Link
CN (1) CN112813134B (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101153316A (en) * 2007-09-14 2008-04-02 内蒙古蒙牛乳业(集团)股份有限公司 Method for detecting lactobacillus casei in probiotic bacteria milk product
CN102242184A (en) * 2011-06-16 2011-11-16 高杰 Detection method for viable counts of strains in bifidobacterium tetravaccine tablets
CN105296591A (en) * 2015-11-26 2016-02-03 佛山市海天(高明)调味食品有限公司 Culture medium for detecting difficult cultivation type lactic acid bacteria in food and detection method thereof
CN105349614A (en) * 2015-12-17 2016-02-24 石家庄君乐宝乳业有限公司 Lactobacillus plantarum specific culture medium and application thereof
CN106191200A (en) * 2016-07-18 2016-12-07 内蒙古农业大学 A kind of method of bulgaricus bacillus in selectivity counting Yoghourt
CN106222240A (en) * 2016-09-18 2016-12-14 石家庄君乐宝乳业有限公司 Lactobacillus fermenti special media and application thereof
US20180179603A1 (en) * 2015-05-21 2018-06-28 Cell Biotech Co., Ltd. Bifidobacterium longum cbt bg7 strain for promotion of growth and nutraceutical composition for promotion of growth containing the same
CN110055301A (en) * 2019-05-06 2019-07-26 上海源本食品质量检验有限公司 A method of the culture medium of detection Bifidobacterium and quickly detection count

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101153316A (en) * 2007-09-14 2008-04-02 内蒙古蒙牛乳业(集团)股份有限公司 Method for detecting lactobacillus casei in probiotic bacteria milk product
CN102242184A (en) * 2011-06-16 2011-11-16 高杰 Detection method for viable counts of strains in bifidobacterium tetravaccine tablets
US20180179603A1 (en) * 2015-05-21 2018-06-28 Cell Biotech Co., Ltd. Bifidobacterium longum cbt bg7 strain for promotion of growth and nutraceutical composition for promotion of growth containing the same
CN105296591A (en) * 2015-11-26 2016-02-03 佛山市海天(高明)调味食品有限公司 Culture medium for detecting difficult cultivation type lactic acid bacteria in food and detection method thereof
CN105349614A (en) * 2015-12-17 2016-02-24 石家庄君乐宝乳业有限公司 Lactobacillus plantarum specific culture medium and application thereof
CN106191200A (en) * 2016-07-18 2016-12-07 内蒙古农业大学 A kind of method of bulgaricus bacillus in selectivity counting Yoghourt
CN106222240A (en) * 2016-09-18 2016-12-14 石家庄君乐宝乳业有限公司 Lactobacillus fermenti special media and application thereof
CN110055301A (en) * 2019-05-06 2019-07-26 上海源本食品质量检验有限公司 A method of the culture medium of detection Bifidobacterium and quickly detection count

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MARIA DILENA等: "A selective medium for isolation and accurate enumeration of Lactobacillus casei-group members in probiotic milks and dairy products", 《INTERNATIONAL DAIRY JOURNAL》 *

Also Published As

Publication number Publication date
CN112813134B (en) 2022-04-26

Similar Documents

Publication Publication Date Title
JP4772131B2 (en) Method for producing fermented milk using novel lactic acid bacteria
EP2082028B1 (en) Microbial liquid cultures having high stability and fermentative activity
JP4862053B2 (en) New lactic acid bacteria
RU2232816C2 (en) STRAIN OF LACTOBACILLUS MICROORGANISM LACTOBACILLUS BULGARICUS CNCM 1-1968 DEVOID β-GALACTOSIDASE ACTIVITY, FERMENT COMPRISING INDICATED STRAIN FOR PREPARING FERMENTED-MILK PRODUCT, FERMENTED-MILK PRODUCT AND METHOD FOR IT PREPARING
CN109536406B (en) Weak post-acidification streptococcus thermophilus JMCC16, separation and purification method and application
FI76373B (en) FOERFARANDE FOER FRAMSTAELLNING AV EN ODLING SOM INNEHAOLLER LEVANDE CELLMASSA AV BIFIDOBAKTERIER OCH MJOELKSYRABAKTERIER.
CN110066750A (en) Streptococcus thermophilus JMCC0024 and isolation and purification method, application
CN113444664B (en) Lactobacillus brevis for producing gamma-aminobutyric acid and application thereof
Kneifel et al. An X-glu based agar medium for the selective enumeration of Lactobacillus acidophilus in yogurt-related milk products
CN112442464A (en) Bifidobacterium breve grx201 resistant to oxidation stress and application thereof
CN112813134B (en) Chromogenic medium, preparation method and strain detection method
CN108004177A (en) A kind of lactobacillus paracasei and its characteristic research of degradable nitrite
CN112813135B (en) Method for detecting cheese strains mixed in lactobacillus plantarum
US4601985A (en) Microorganism belonging to streptococcus thermophilus and a composition containing said microorganism
EP4166646A1 (en) Method for isolating lactic acid bacteria (lab) from complex samples
CN109022307B (en) Streptococcus thermophilus with high urease activity and application thereof
EP2069475B1 (en) Culture media formulations for industrial application
RU2674583C1 (en) Method for the differential enumeration of lactic acid bacteria in mixture in food product
JP2009232716A (en) New lactic acid bacterium
KR20100005552A (en) Fermented milk using lactobacillus plantarum m23 and preparation method thereof
JP4794593B2 (en) Method for producing fermented milk using novel lactic acid bacteria
CN113981035B (en) Combined diluent for culturing bifidobacteria, use method thereof and detection method of bifidobacteria
Gawai et al. Activity And Purity Tests Of Starter Cultures
SU1386658A1 (en) Strain of streptococcus acetoinicus bacteria used for producing sourish milk products
KR20100005519A (en) Fermented milk using lactobacillus zeae rmk354 and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 050800 No. 16, bangxiu East Road, North District, high tech Industrial Development Zone, Zhengding County, Zhengding District, China (Hebei) pilot Free Trade Zone, Shijiazhuang City, Hebei Province

Applicant after: Hebei Yiran Biotechnology Co.,Ltd.

Address before: 050899 China (Hebei) pilot Free Trade Zone, Zhengding District, Zhengding County, Shijiazhuang City, Hebei Province

Applicant before: HEBEI INATURAL BIOTECHNOLOGY Co.,Ltd.

CB02 Change of applicant information
GR01 Patent grant
GR01 Patent grant